Anti-GD1a Monoclonal Antibody1vial

3-(5-Methyl-1H-imidazol-1-yl)propan-1-amine, 95%, 1g

(4-methyl-1,3-thiazol-2-yl)methanol hydrochloride, 95.0%, 1g

(R)-3-(Dodecanoyloxy)-2-hydroxypropyl (2-(trimethylammonio)ethyl) phosphate, 99%, 1g

2-(1-AMINOCYCLOPENTYL)ACETONITRILE HCL, 97.0%, 100mg

6-fluoro-2-(prop-1-en-2-yl)benzo[d]oxazole, 96% mix TBC as stabilizer, 250mg

2-Fluoro-6-nitrobenzonitrile, 95.0%, 25g

(3-Cyano-4-hydroxyphenyl)boronic acid, 97%, 250mg

1-METHYL-4-((TRIMETHYLSILYL)ETHYNYL)-1H-PYRAZOLE, 95%, 100mg

Methyl 2-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate, 97.0%, 1g

(3-(3-Ethoxy-3-oxopropyl)phenyl)boronic acid, 95.0%, 100mg

2-CHLORO-4-FLUORO-5-NITROPHENYL METHYL CARBONATE, 95.0%, 2g

4,5-Difluoro-2-iodophenol, 97%, 250mg